Revenue Breakdown
Composition ()
No data
Revenue Streams
ENvue Medical Inc (FEED) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is NanoVibronix, accounting for 81.8% of total sales, equivalent to $534.00K. Another important revenue stream is ENvue. Understanding this composition is critical for investors evaluating how FEED navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, ENvue Medical Inc maintains a gross margin of -8.42%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -568.30%, while the net margin is -585.30%. These profitability ratios, combined with a Return on Equity (ROE) of -110.87%, provide a clear picture of how effectively FEED converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, FEED competes directly with industry leaders such as CLGN and HSCS. With a market capitalization of $5.49M, it holds a significant position in the sector. When comparing efficiency, FEED's gross margin of -8.42% stands against CLGN's -220.00% and HSCS's 59.06%. Such benchmarking helps identify whether ENvue Medical Inc is trading at a premium or discount relative to its financial performance.
